In terms of SLE manifestations, the frequency of lymphopenia is lower in anti‐AHNAK1 antibody positive SLE patients (13/17, 76.4%) compared to anti‐AHNAK1 antibody negative SLE patients (40/42, 95.2%), although no significant differences were observed in other disease manifestations. This evidence concerns the gene AHNAK and systemic lupus erythematosus.